A Non Interventional Study To Asses The Safety, Effectiveness And Tolerability Of Quinapril (Acupil®) In An Indian Population

CompletedOBSERVATIONAL
Enrollment

329

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Hypertension
Interventions
DRUG

quinapril

per label as non interventional study

Trial Locations (18)

20

Pfizer Investigational Site, Kolkata

110017

Pfizer Investigational Site, Delhi

208005

Pfizer Investigational Site, Kanpur

625003

Pfizer Investigational Site, Madurai

625014

Pfizer Investigational Site, Madurai

01

Pfizer Investigational Site, Patna

380 015

Pfizer Investigational Site, Ahmedabad

Pfizer Investigational Site, Ahmedabad

560 003

Pfizer Investigational Site, Bangalore

560 051

Pfizer Investigational Site, Bangalore

440 015

Pfizer Investigational Site, Nagpur

440 033

Pfizer Investigational Site, Nagpur

411 004

Pfizer Investigational Site, Pune

302 020

Pfizer Investigational Site, Jaipur

600 035

Pfizer Investigational Site, Chennai

625 010

Pfizer Investigational Site, Madurai

625 107

Pfizer Investigational Site, Madurai

620 021

Pfizer Investigational Site, Trichy

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00930722 - A Non Interventional Study To Asses The Safety, Effectiveness And Tolerability Of Quinapril (Acupil®) In An Indian Population | Biotech Hunter | Biotech Hunter